NextRX is the First Cannabis Related Startup to Launch an Equity Crowdfunding Campaign

Santa Monica, CA, January 26, 2017 (Newswire.com) - ​​​NextRX, Inc “The Rewarding Membership Network” for Cannabis Dispensaries, that owns an innovative RX-System making registration and check-in for medical marijuana patients more secure and convenient launches its equity crowdfunding campaign on Fundanna.com.

Approved by the SEC and launched in January 2017 Fundanna (FINRA member) is the first and the only Regulation Crowdfunding (Reg CF) funding portal in the USA working exclusively with Cannabis-related businesses.

By using Fundanna.com, NextRX will appeal to the crowd rather than just to the accredited investors (those with $1 million in assets and $200k+ income) to build a base of potential evangelists while also gaining funding. It is a win-win situation. For the first time regular individuals and not just the wealthy can get a piece of the green rush.

Ralf-Rainer von Albedyhll, CEO of NextRX, Inc

NextRX developed an exclusive RX-Pass system to allow patients to register quickly and easily through a method where all patient information is stored securely offsite.

After registering, new patients are issued their own RX-Pass that they receive on their smartphone so the check-in is just a matter of a simple scan. The system automatically checks that all necessary documents are on file and valid. To prevent fraud, the staff compares the patient’s picture in the system to the person. Once completed, the system will include RX-Points where patients earn reward points for every dollar spent that they can use to pay for medicine at any subscribing dispensary.

In May 2016, NextRX was the first Cannabis company launching its campaign on a funding portal, via StartEngine. The excitement lasted less than 48 hours as there was no escrow agent willing and able to transact into the Cannabis space.

Even if NextRX could not take advantage of the crowdfunding benefits in 2016, they continued to develop their system and registered over 16,000 patients through a few beta user dispensaries. The vision is to ultimately develop what they call the Rewarding Membership Network where patients earn points for their purchase that are used as cash at all subscribing dispensaries. Think miles for pot.

"By using Fundanna.com, NextRX will appeal to the crowd rather than just to the accredited investors (those with $1 million in assets and $200k+ income) to build a base of potential evangelists while also gaining funding. It is a  win-win situation. For the first time regular individuals and not just the wealthy can get a piece of the green rush," says Ralf-Rainer von Albedyhll, CEO of NextRX, Inc.

“The cannabis industry is expected to hit $11 billion in 2018. The big advantage for the retail investor is that they can finally get into the Cannabis investments. What is even greater is that they can do it at an early stage when the valuation is around $2 million and not $ 40 million, 100 million or more,” says Vincent Petrescu CEO of Fundanna. “Simply put, the few hundreds invested will buy a bigger portion of the company, but of course, at a higher risk level.”

NextRX is proud to be the first listing on Fundanna. The company will be launching its campaign at the NextPitchLA event in Santa Monica, California on January 26, 2017.

Source: NextRX, Inc